LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | TGX221 | 0.04 | uM | LJP5 | 1 | H24 | 72 | hr | 1476 | 3145 | 3694 | 0.8514 | 0.7524 |
SK-BR-3 | TGX221 | 0.04 | uM | LJP5 | 2 | H24 | 72 | hr | 1476 | 2898 | 3694 | 0.7845 | 0.6410 |
SK-BR-3 | TGX221 | 0.04 | uM | LJP5 | 3 | H24 | 72 | hr | 1476 | 2779 | 3694 | 0.7523 | 0.5873 |
SK-BR-3 | Torin1 | 0.04 | uM | LJP6 | 1 | O18 | 72 | hr | 1476 | 1510 | 3694 | 0.4088 | 0.0150 |
SK-BR-3 | Torin1 | 0.04 | uM | LJP6 | 2 | O18 | 72 | hr | 1476 | 1518 | 3694 | 0.4109 | 0.0186 |
SK-BR-3 | Torin1 | 0.04 | uM | LJP6 | 3 | O18 | 72 | hr | 1476 | 1541 | 3694 | 0.4172 | 0.0290 |
SK-BR-3 | Torin2 | 0.04 | uM | LJP5 | 1 | I24 | 72 | hr | 1476 | 1448 | 3694 | 0.3920 | -0.0130 |
SK-BR-3 | Torin2 | 0.04 | uM | LJP5 | 2 | I24 | 72 | hr | 1476 | 1299 | 3694 | 0.3517 | -0.0802 |
SK-BR-3 | Torin2 | 0.04 | uM | LJP5 | 3 | I24 | 72 | hr | 1476 | 1184 | 3694 | 0.3205 | -0.1320 |
SK-BR-3 | Tozasertib | 0.04 | uM | LJP5 | 1 | B18 | 72 | hr | 1476 | 1176 | 3694 | 0.3184 | -0.1356 |
SK-BR-3 | Tozasertib | 0.04 | uM | LJP5 | 2 | B18 | 72 | hr | 1476 | 1291 | 3694 | 0.3495 | -0.0838 |
SK-BR-3 | Tozasertib | 0.04 | uM | LJP5 | 3 | B18 | 72 | hr | 1476 | 1135 | 3694 | 0.3073 | -0.1541 |
SK-BR-3 | Trametinib | 0.04 | uM | LJP5 | 1 | P24 | 72 | hr | 1476 | 2426 | 3694 | 0.6567 | 0.4281 |
SK-BR-3 | Trametinib | 0.04 | uM | LJP5 | 2 | P24 | 72 | hr | 1476 | 2532 | 3694 | 0.6854 | 0.4759 |
SK-BR-3 | Trametinib | 0.04 | uM | LJP5 | 3 | P24 | 72 | hr | 1476 | 2320 | 3694 | 0.6280 | 0.3803 |
SK-BR-3 | TWS119 | 0.04 | uM | LJP5 | 1 | M06 | 72 | hr | 1476 | 3900 | 3694 | 1.0558 | 1.0929 |
SK-BR-3 | TWS119 | 0.04 | uM | LJP5 | 2 | M06 | 72 | hr | 1476 | 3663 | 3694 | 0.9916 | 0.9860 |
SK-BR-3 | TWS119 | 0.04 | uM | LJP5 | 3 | M06 | 72 | hr | 1476 | 4053 | 3694 | 1.0972 | 1.1619 |
SK-BR-3 | Vemurafenib | 0.04 | uM | LJP5 | 1 | C18 | 72 | hr | 1476 | 3766 | 3694 | 1.0195 | 1.0324 |
SK-BR-3 | Vemurafenib | 0.04 | uM | LJP5 | 2 | C18 | 72 | hr | 1476 | 4051 | 3694 | 1.0966 | 1.1610 |
SK-BR-3 | Vemurafenib | 0.04 | uM | LJP5 | 3 | C18 | 72 | hr | 1476 | 4186 | 3694 | 1.1332 | 1.2219 |
SK-BR-3 | Withaferin A | 0.04 | uM | LJP5 | 1 | G18 | 72 | hr | 1476 | 3658 | 3694 | 0.9902 | 0.9837 |
SK-BR-3 | Withaferin A | 0.04 | uM | LJP5 | 2 | G18 | 72 | hr | 1476 | 3954 | 3694 | 1.0704 | 1.1172 |
SK-BR-3 | Withaferin A | 0.04 | uM | LJP5 | 3 | G18 | 72 | hr | 1476 | 3893 | 3694 | 1.0539 | 1.0897 |
SK-BR-3 | Withaferin A | 0.04 | uM | LJP6 | 1 | G18 | 72 | hr | 1476 | 3453 | 3694 | 0.9348 | 0.8913 |